Evidence map›Paper›PMID 34742326›Full record

ArticleParasites & vectors2021

Effect of mast cell stabilization on angiogenesis in primary and secondary experimental Trichinella spiralis infection.

Marwa A El-Dardiry, Amany A Abdel-Aal, Magda S A Abdeltawab, Mona El-Sherbini, Marwa A Hassan, Asmaa A Abdel-Aal, Manal Badawi, Shady E Anis, Bahaa-Eldin A Khaled, Abeer S Al-Antably

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Investigating therapeutic efficacy of silymarin on intestinal and muscular phases of trichinellosis: an experimental study.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  5. Host angiogenic reprogramming byFrontiers in microbiology · 2025
    Article
  6. Pathogens (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marwa A El-DardiryDepartment of Medical Parasitology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. marwaahmed2008@outlook.com.ORCID http://orcid.org/0000-0003-2105-8896
Amany A Abdel-AalDepartment of Medical Parasitology, Faculty of Medicine, Cairo University, Giza, Egypt.
Magda S A AbdeltawabDepartment of Medical Parasitology, Faculty of Medicine, Cairo University, Giza, Egypt.
Mona El-SherbiniDepartment of Medical Parasitology, Faculty of Medicine, Cairo University, Giza, Egypt.
Marwa A HassanDepartment of Medical Parasitology, Faculty of Medicine, Cairo University, Giza, Egypt.
Asmaa A Abdel-AalDepartment of Clinical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Manal BadawiDepartment of Pathology, National Research Center, Giza, Egypt.
Shady E AnisDepartment of Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Bahaa-Eldin A KhaledDepartment of Anatomy & Embryology, Faculty of Medicine, Cairo University, Giza, Egypt.
Abeer S Al-AntablyDepartment of Medical Parasitology, Faculty of Medicine, Cairo University, Giza, Egypt.
Cairo University · EGFayoum University · EGNational Water Research Center · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMast cells are known to affect the primary and secondary immune responses against parasites, and this effect is partially mediated through the release of pro-angiogenic mediators. The aim of this study was to explore the effect of the mast cell stabilizer (MCS), ketotifen, with and without albendazole, an anti-parasitic prescription medicine, on the inflammatory response against Trichinella spiralis, with the overall aim to investigate its effect on angiogenesis accompanying nurse cell formation.

methodsThe effect of ketotifen and albendazole was explored in eight groups of female BALB/c mice. Four groups were sensitized with a small dose of T. spiralis larvae. The drug regimen was then applied to both sensitized (challenged) and non-sensitized mice. The parasite load was assessed by histopathological examination of the small intestine and muscle tissue, and angiogenesis was assessed by immunohistochemistry to determine the expression of vascular endothelial growth factor (VEGF).

resultsSensitized mice showed a significantly lower parasite load and a more pronounced inflammatory response than mice receiving a single infective dose of T. spiralis larvae. All treated groups showed a significant reduction in parasite count compared to the control groups (groups IAa and IBa), reaching approximately an 98.8% reduction in adult parasite count in the sensitized group treated with albendazole (groups IIAb and IIBb). MCS significantly decreased the parasite count during both the intestinal or muscular phases, reduced tissue inflammation, and decreased local VEGF expression, both in the non-sensitized and sensitized groups.

conclusionSensitization with a low dose of T. spiralis larvae was found to confer a partial protective immunity against re-infection and to positively affect the study outcomes, thus underlining the importance of vaccination, but after extensive studies. The anti-angiogenic effect of MCS protects against larval encystation during the muscle phase. The anti-angiogenic potential of albendazole suggests that the action of this anti-helminthic during trichinellosis is not confined to structural damage to the parasite cuticle but includes an effect on host immunopathological response.

Indexed as

AlbendazoleAnimalsAnthelminticsDrug Therapy, CombinationFemaleHumansKetotifenMast CellsMast Cell StabilizersMiceMice, Inbred C57BLNeovascularization, PathologicTrichinella spiralisTrichinellosisAlbendazoleAnthelminticsKetotifenMast Cell StabilizersAlbendazoleAngiogenesisKetotifenMast cellsT. spiralisVEGF

Identifiers

PMID34742326
PMCPMC8572477
OpenAlexW3211386007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.